All posts by: Michael Zand

Indonesia wants to up stem cell work – PNG Industry News (press release) (subscription)

Bringing Back the Dead – Highlands Current

Highlands CurrentBringing Back the DeadHighlands CurrentDe-extinction is usually thought of as part of the larger field of synthetic biology, and synthetic biology is rife with values questions. Synthetic biology might allow you not only to re-create e… Continue reading

Dr Lee Newcomer on Policy Decisions as New Immunotherapy Agents Are Developed – AJMC.com Managed Markets Network

AJMC.com Managed Markets NetworkDr Lee Newcomer on Policy Decisions as New Immunotherapy Agents Are DevelopedAJMC.com Managed Markets NetworkLee N. Newcomer, MD, MHA, senior vice president of oncology and genetics at UnitedHealthcare, discusses off-lab… Continue reading

First US FDA approval of CAR-T therapy hikes expectations for Korean biotech ventures – The Korea Herald

The Korea HeraldFirst US FDA approval of CAR-T therapy hikes expectations for Korean biotech venturesThe Korea HeraldCAR-T cell therapies are widely expected to form a new wave in the realm of cancer treatments, going beyond traditional methods includi… Continue reading

CRISPR technology used to change flower color – Science Daily

Science DailyCRISPR technology used to change flower colorScience DailyIn a world-first, Japanese scientists have used the revolutionary CRISPR, or CRISPR/Cas9, genome- editing tool to change flower colour in an ornamental plant. Researchers from the … Continue reading

CD19-Specific CAR T-Cell Therapy Effective in Ibrutinib-Refractory CLL – Cancer Network

CD19-Specific CAR T-Cell Therapy Effective in Ibrutinib-Refractory CLLCancer NetworkAnti-CD19 chimeric antigen receptor (CAR)-modified T-cell therapy was highly effective in patients with high-risk chronic lymphocytic leukemia (CLL) who had previously … Continue reading

Liquid Biopsy for Mutation Burden Predicts PFS in NSCLC Immunotherapy – OncLive